As of 12/31/2024, Tracenable has captured detailed data on Amgen's corporate ownership structure, offering an in-depth view of its significant subsidiaries and their importance within the group.a
The dataset includes information on 44 subsidiaries, identified as material based on their financial importance, operational scale, or strategic contribution to Amgen's consolidated operations.a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
Amgen (Europe) GmbHa | CHE | Subsidiary | Not Specified | ||
Amgen Canada Inc.a | CAN | Subsidiary | Not Specified | ||
Amgen Fremont Inc.a | USA | Subsidiary | Not Specified | ||
Amgen Global Finance B.V.a | NLD | Subsidiary | Not Specified | ||
Amgen Global Technology Unlimited Companya | IRL | Subsidiary | Not Specified | ||
Amgen GmbH Germanya | DEU | Subsidiary | Not Specified | ||
Amgen Ilaç Ticaret Limited Şirketia | TUR | Subsidiary | Not Specified | ||
Amgen International Holdings Inc.a | USA | Subsidiary | Not Specified | ||
Amgen K.K.a | JPN | Subsidiary | Not Specified | ||
Amgen K-A, Inc.a | USA | Subsidiary | Not Specified | ||
Amgen Manufacturing Limited LLCa | PRI | Subsidiary | Not Specified | ||
Amgen Mexico, S.A. de C.V.a | MEX | Subsidiary | Not Specified | ||
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| Showing 12 out of 44 entities. Get complete coverage in the full dataset. | |||||
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
Tracenable's group entities dataset provides geographic insights into Amgen's significant subsidiaries, revealing their location around the world.a
In total, the Amgen group includes 44 significant subsidiaries distributed across 16 countries, illustrating the company's governance network, operational footprint, and geographical consolidation structure.a
This visualization highlights the geographical distribution of Amgen's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape.a
In 2024, Tracenable identified that the Amgen group consisted of44 significant subsidiaries, located across 16 countries.a
This represents a focused geographic presence, reflecting the company's core operational centers or key strategic markets rather than a full view of its global entity network.a
Amgen's significant subsidiaries are primarily located in North America and Europe, which together host 90.91% of its material entities.a
This concentration suggests that the company's strategic and operational priorities are centered in these key markets, consistent with its focus on financially material or high-impact operations.
Amgen exhibits a limited level of transparency concerning its corporate ownership structure.
The disclosure covers only a small number of significant subsidiaries, typically those with material financial or operational relevance.a
Without full group hierarchy or equity details, it offers a restricted view of Amgen's broader ownership network, making it harder to assess the company's consolidated structure or cross-entity control.
Yes. Tracenable's data shows that 2 entities (4.55%) are registered in jurisdictions commonly classified as low-tax or offshore financial centers, such as Bermuda.a
This may indicate tax optimization strategies or the use of special-purpose vehicles (SPVs) within Amgen's ownership structure.